SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Allergan Inc. Buys Co-Promotion Rights on MAP Pharmaceuticals, Inc. Migraine Drug; Deal Worth up to $157M

January 31, 2011 | 
1 min read
BANGALORE, Jan 31 (Reuters) - Allergan Inc (AGN.N) bought co-promotion rights on Map Pharmaceuticals Inc's (MAPP.O) experimental treatment for acute migraine for $60 million in upfront payment, in a move to expand its migraine franchise.
Mergers & acquisitions Asia
MORE ON THIS TOPIC
Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad
Obesity
Novo buys three early-stage obesity assets from Kallyope as investor pressure mounts
September 21, 2026
 · 
1 min read
 · 
Tristan Manalac
Symbolic image: Tablets, US Dollar and China - Dependence on the Chinese pharmaceutical industry
China
China plans to transform biotech sector into $522B powerhouse by 2030
September 18, 2026
 · 
2 min read
 · 
Annalee Armstrong
The intertwining wires flash in different colors, 3D rendering illustration.
IPO
Electra lights up with $350M IPO for pivotal immune-disease drug development
September 18, 2026
 · 
1 min read
 · 
Gabrielle Masson
Bridging the gap connect the path to success together, teamwork or partnership, collaboration or cooperation for winning challenge, businessman connect jigsaw puzzle as the bridge to connect the gap.
Deals
Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs
September 17, 2026
 · 
2 min read
 · 
Michael Gibney